Gilead Sciences (GILD) PT Raised to $88 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Gilead (GILD) delivers mixed Q1 results; Analysts focused on upcoming catalysts
April 28, 2023 6:21 AM EDTGilead Sciences (NASDAQ: GILD) reported weaker-than-expected profit figures for its first quarter.
EPS came in at $1.37, worse than the $1.53 expected while Q1 revenue was ahead of market views - $6.4 billion vs $6.31B. Overall, sales fell 3.6% year-over-year as product sales dropped 3.5%.
Gileads track... More
